MedPath

Exercise and Two Different Kinesiotape Applications in Patients With Sacroiliac Joint Dysfunction

Not Applicable
Completed
Conditions
Sacroiliac Joint Dysfunction
Registration Number
NCT04829513
Lead Sponsor
Ufuk University
Brief Summary

This study is a randomized controlled study. 99 patients between the ages of 18-65 who were diagnosed with sacroiliac joint dysfunction will be included in the study.

Detailed Description

33 patients will be given a home exercise program that strengthens the waist and hip girdle (to be shown once in the hospital by a physiotherapist and the form of the exercises will be given), 33 patients will be given kinesiotaping (KT) with ligament correction technique with the exercise program, and 33 patients will be given kinesiotaping with lymphatic correction technique with the exercise program. Patients will do the exercises once a day for 1 month. KT will be repeated once a week for 3 weeks. When taping is performed, it will be kept for 5 days.The patients' pain at rest and during movement will be measured using the Visuel Analog Scale (VAS). Patient Global Assessment and Oswestry Disability Index (ODI) will be questioned. Evaluations will be performed before, 4th week and 1 month after treatment (8th week).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria
  • Patients with sacroiliac joint dysfunction between the ages of 18-65
Exclusion Criteria
  • Patients with rheumatological inflammatory disease
  • Inflamatory sacroiliitis
  • Patients with polyarthrosis, herniated disc, severe symptomatic disc degeneration, spinal stenosis and spondyloarthrosis.
  • Patients with a history of pelvic trauma
  • Patients with metabolic bone disease, infection, malignancy, pregnancy
  • Patients with open wounds in the lumbar and sacral area

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain at movementBefore treatment (T1), After treatment at 4th week (T2), Follow-up at 8th week (T3)

Pain at movement will be measured using the Visuel Analog Scale (0-10 cm).Patients are asked to rate their pain at rest over the past week and to mark a point on a 10 cm line with endpoints '0 = no pain' and '10 = worst pain imaginable'. The distance (cm) measured from the 'no pain' endpoint to the point marked by the patient is reported as the VAS score.

Pain at restBefore treatment (T1), After treatment at 4th week (T2), Follow-up at 8th week (T3)

Pain at rest will be measured using the Visuel Analog Scale (0-10 cm).Patients are asked to rate their pain at rest over the past week and to mark a point on a 10 cm line with endpoints '0 = no pain' and '10 = worst pain imaginable'. The distance (cm) measured from the 'no pain' endpoint to the point marked by the patient is reported as the VAS score.

Secondary Outcome Measures
NameTimeMethod
Patient Global AssessmentBefore treatment (T1), After treatment at 4th week (T2), Followup at 8th week (T3)

Patient Global Assessment in the last week will be questioned by Visuel Analog Scale. Patients will be asked to mark their global assessment on a 0-10 cm visual analog scale (0:very good -10: very poor). Lower values indicate better status.

Oswestry Disability IndexBefore treatment (T1), After treatment at 4th week (T2), Followup at 8th week (T3)

Oswestry Disability Index will be questioned to determine the level of disability.The degree of disability is quantified on a scale of 0 to 100%. As the total score increases, the level of disability also increases.

Trial Locations

Locations (1)

Ufuk University

🇹🇷

Ankara, Turkey

Ufuk University
🇹🇷Ankara, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.